NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫藥品連續生產的全球市場:2027年前的預測,新型冠狀病毒感染疾病(COVID-19)的影響與全球市場分析

Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application; End User and Geography

出版商 The Insight Partners 商品編碼 935345
出版日期 內容資訊 英文 239 Pages
訂單完成後即時交付
價格
醫藥品連續生產的全球市場:2027年前的預測,新型冠狀病毒感染疾病(COVID-19)的影響與全球市場分析 Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application; End User and Geography
出版日期: 2020年04月27日內容資訊: 英文 239 Pages
簡介

全球醫藥品連續生產的市場預測將從2019年的14億5,953萬美元達到2027年30億6,438萬美元,從2020年到2027年的年複合成長率預計成為9.8%。

本報告提供全球醫藥品連續生產市場調查,提供市場概況和動態,各產品,各用途,各終端用戶,各地區的分析,COVID-19大流行病的影響,產業狀況,企業簡介等資訊。

目錄

第1章 簡介

  • 調查範圍
  • 調查報告的指導
  • 市場區隔

第2章 主要調查結果

第3章 調查手法

  • 調查範圍
  • 2次調查
  • 1次調查

第4章 市場的狀況

  • 概要
  • PEST分析
  • 專家的意見

第5章 市場力學

  • 成長促進因素
  • 成長阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 世界市場收益預測與分析
  • 各地區的收益預測與分析
  • 主要企業的立場

第7章 市場分析:各產品

  • 概要
  • 市場佔有率:各產品
  • 整合系統
  • 半連續系統
  • 控制系統

第8章 市場分析:各用途

  • 概要
  • 市場佔有率:各用途
  • 最終產品的製造
  • 原料藥的製造

第9章 市場分析:各終端用戶

  • 概要
  • 市場佔有率:各終端用戶
  • 滿量程的醫藥品廠商
  • 研究開發部門

第10章 各地區市場分析

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東·非洲
    • 沙烏地阿拉伯
    • UAE
    • 南非
  • 南美
    • 巴西
    • 阿根廷

第11章 COVID-19大流行病的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 產業情勢

  • 概要
  • 成長策略

第13章 企業簡介

  • GEA Group
  • Coperion GmbH
  • Gericke AG
  • Glatt GmbH
  • Hosokawa Micron Group
  • Munson Machinery Co., Inc.
  • Powrex Corp
  • THERMO FISHER SCIENTIFIC INC.
  • ACG
  • Cadmach Machinery Co. Pvt. Ltd.
  • Fette Compacting
  • Freund-Vector Corporation
  • KORSCH AG
  • LEISTRITZ AG
  • ALEXANDERWERK AG
  • Hovione

第14章 附錄

目錄
Product Code: TIPRE00008245

The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027.

The growth of the market is attributed to key driving factors such as increasing shortage of medicines and advantages offered by continuous manufacturing process. However, high capital costs required for the establishment of these systems expected to restrain the growth of the market during the forecast period.

Batch manufacturing have been the most common and traditionally used mode of manufacturing in the pharmaceuticals industry for more than a century. However, with the rising demand for biologics and increasing trend of contract manufacturing, the flexible manufacturing alternatives such as continuous manufacturing processes are being embraced and gaining importance in the recent years. The FDA is passing quick approvals to companies transitioning from batch production to continuous manufacturing procedures. In 2016, Orkambi by Vertex Pharmaceuticals was the first manufacturer to go "batch-less" on their production lines. Furthermore, in April 2019, Janssen Pharmaceuticals, a division of Johnson & Johnson Services, Inc., switched to continuous manufacturing process for the development of active pharmaceutical ingredients (API) due to the advantages offered by this process in terms of streamlining the manufacturing procedure and ability to accelerate procedures. Continuous pharmaceutical manufacturing involves a drug taken from its base ingredients to final product with no need of halt or stop during the production. According to the Food and Drug Administration (FDA), the pharmaceutical manufacturing industry wastes up to US$ 50 billion every year on an average on inefficient processes. Continuous manufacturing serves to be a potential solution for the same problem. In addition, there are various other advantages offered by the continuous process that include more time-efficiency, reduced energy needs, and increased productivity, as well as reduction in overall wastage amounts. Furthermore, the risk of human error is also reduced in the continuous process due to a smaller number of people involved in the manufacturing process. Thus, the advantages offered by continuous manufacturing over batch manufacturing procedure are expected to drive the growth of the market over the coming years.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and geography. The pharmaceutical continuous manufacturing market, by product, is segmented into integrated systems, semi-continuous systems, and controls. In 2019, the integrated systems segment accounted for the largest market share of the global pharmaceutical continuous manufacturing market. The integrated systems are expected to dominate the product segment owing to their easy availability and accessibility as well as higher adoption of these systems as compared with the semi-continuous systems and the controls. The integrated systems help build the continuous flow during manufacturing process, facilitate end-to-end integration, and improve asset utilization. Based on application, the market is segmented into end product manufacturing and API manufacturing. Based on end user, the market is segmented into full-scale manufacturing companies and R&D departments.

Some of the crucial secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, Rashtriya Swasthya Bima Yojna, Health Canada, and European Medical Agency (EMA).

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical continuous manufacturing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical continuous manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Pharmaceutical Continuous Manufacturing Market - By Product
    • 1.3.2 Global Pharmaceutical Continuous Manufacturing Market - By Application
    • 1.3.3 Global Pharmaceutical Continuous Manufacturing Market - By End User
    • 1.3.4 Global Pharmaceutical Continuous Manufacturing Market - By Geography

2. Pharmaceutical Continuous Manufacturing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Pharmaceutical Continuous Manufacturing - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
    • 4.2.4 Middle East & Africa
    • 4.2.5 South and Central America
  • 4.3 Expert Opinion

5. Global Pharmaceutical Continuous Manufacturing Market - Industry Dynamics

  • 5.1 Key Drivers
    • 5.1.1 Increasing Shortage of Medicines
    • 5.1.2 Advantages Offered by Continuous Manufacturing Process
  • 5.2 Key Market Restraints
    • 5.2.1 High Capital Investments
  • 5.3 Key Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
  • 5.5 Impact Analysis

6. Pharmaceutical Continuous Manufacturing Market - Global Analysis

  • 6.1 Global Pharmaceutical Continuous Manufacturing Market Revenue Forecast And Analysis
  • 6.2 Global Pharmaceutical Continuous Manufacturing Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Pharmaceutical Continuous Manufacturing Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
  • 7.3 Integrated Systems
    • 7.3.1 Overview
    • 7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Semi-Continuous Systems
    • 7.4.1 Overview
    • 7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.3 Continuous Granulators
      • 7.4.3.1 Overview
      • 7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.4 Continuous Blenders
      • 7.4.4.1 Overview
      • 7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.5 Continuous Compressors
      • 7.4.5.1 Overview
      • 7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.6 Continuous Coaters
      • 7.4.6.1 Overview
      • 7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.7 Continuous Dryers
      • 7.4.7.1 Overview
      • 7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.8 Other Semi-Continuous Systems
      • 7.4.8.1 Overview
      • 7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Controls
    • 7.5.1 Overview
    • 7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)

8. Pharmaceutical Continuous Manufacturing Market- By Application

  • 8.1 Overview
  • 8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
  • 8.3 End Product Manufacturing
    • 8.3.1 Overview
    • 8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
    • 8.3.3 Solid Dosage Manufacturing
      • 8.3.3.1 Overview
      • 8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
    • 8.3.4 Liquid Dosage Manufacturing
      • 8.3.4.1 Overview
      • 8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • 8.4 API Manufacturing
    • 8.4.1 Overview
    • 8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)

9. Pharmaceutical Continuous Manufacturing Market - By End User

  • 9.1 Overview
  • 9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
  • 9.3 Full-Scale Manufacturing Companies
    • 9.3.1 Overview
    • 9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
    • 9.3.3 Pharmaceutical Companies
      • 9.3.3.1 Overview
      • 9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
    • 9.3.4 Contract Manufacturing Organizations
      • 9.3.4.1 Overview
      • 9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • 9.4 R&D Departments
    • 9.4.1 Overview
    • 9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
    • 9.4.3 Contract Research Organizations
      • 9.4.3.1 Overview
      • 9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
    • 9.4.4 Research Institutes
      • 9.4.4.1 Overview
      • 9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)

10. Pharmaceutical Continuous Manufacturing Market - Geographic Analysis

    • 10.1.1 Overview
    • 10.1.2 North America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 10.1.3.1 North America: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
    • 10.1.4 North America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
      • 10.1.4.1 North America: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
    • 10.1.5 North America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
      • 10.1.5.1 North America: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
      • 10.1.5.2 North America: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.1.6 North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.1.7.2.1 US: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.1.7.3 US: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.1.7.3.1 US: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.1.7.4 US: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.1.7.4.1 US: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.1.7.4.2 US: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.1.8 Canada: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.1.8.2.1 Canada: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.1.8.3 Canada: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.1.8.3.1 Canada: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.1.8.4 Canada: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.1.8.4.1 Canada: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.1.8.4.2 Canada: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.1.9 Mexico: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.1.9.2.1 Mexico: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.1.9.3 Mexico: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.1.9.3.1 Mexico: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.1.9.4 Mexico: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.1.9.4.1 Mexico: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.1.9.4.2 Mexico: R&D Departments Market, by Type, 2018-2027 (USD Million)
  • 10.2 Europe: Pharmaceutical Continuous Manufacturing Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 10.2.3.1 Europe: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
    • 10.2.4 Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
      • 10.2.4.1 Europe: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
    • 10.2.5 Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
      • 10.2.5.1 Europe: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
      • 10.2.5.2 Europe: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.2.6 Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
    • 10.2.7 Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.2.7.2.1 Germany: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.2.7.3 Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.2.7.3.1 Germany: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.2.7.4 Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.2.7.4.1 Germany: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.2.7.4.2 Germany: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.2.8 UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.2.8.2.1 UK: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.2.8.3 UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.2.8.3.1 UK: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.2.8.4 UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.2.8.4.1 UK: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.2.8.4.2 UK: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.2.9 France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.2.9.2.1 France: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.2.9.3 France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.2.9.3.1 France: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.2.9.4 France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.2.9.4.1 France: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.2.9.4.2 France: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.2.10 Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.2.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.2.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.2.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.2.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.2.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.2.10.4.2 Spain: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.2.11 Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.2.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.2.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.2.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.2.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.2.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.2.11.4.2 Italy: R&D Departments Market, by Type, 2018-2027 (USD Million)
  • 10.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 10.3.2.1 Asia Pacific: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
    • 10.3.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
      • 10.3.3.1 Asia Pacific: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
    • 10.3.4 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
      • 10.3.4.1 Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
      • 10.3.4.2 Asia Pacific: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.3.5 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
    • 10.3.6 China: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.6.1 China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.3.6.1.1 China: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.3.6.2 China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.3.6.2.1 China: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.3.6.3 China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.3.6.3.1 China: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.3.6.3.2 China: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.3.7 Japan: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.3.7.1.1 Japan: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.3.7.2 Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.3.7.2.1 Japan: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.3.7.3 Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.3.7.3.1 Japan: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.3.7.3.2 Japan: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.3.8 India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.3.8.2.1 India: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.3.8.3 India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.3.8.3.1 India: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.3.8.4 India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.3.8.4.1 India: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.3.8.4.2 India: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.3.9 South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.3.9.2.1 South Korea: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.3.9.3 South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.3.9.3.1 South Korea: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.3.9.4 South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.3.9.4.1 South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.3.9.4.2 South Korea: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.3.10 Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.3.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.3.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.3.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.3.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.3.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.3.10.4.2 Australia: R&D Departments Market, by Type, 2018-2027 (USD Million)
  • 10.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
    • 10.4.3 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 10.4.3.1 Middle East & Africa: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
    • 10.4.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
      • 10.4.4.1 Middle East & Africa: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
    • 10.4.5 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
      • 10.4.5.1 Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
      • 10.4.5.2 Middle East & Africa: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.4.6 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country - 2019 & 2027, (%)
    • 10.4.7 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.4.7.2.1 Saudi Arabia: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.4.7.3.1 Saudi Arabia: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.4.7.4 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.4.7.4.1 Saudi Arabia: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.4.7.4.2 Saudi Arabia: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.4.8 UAE: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.4.8.2.1 UAE: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.4.8.3 UAE: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.4.8.3.1 UAE: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.4.8.4 UAE: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.4.8.4.1 UAE: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.4.8.4.2 UAE: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.4.9 South Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
      • 10.4.9.1 South Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.4.9.2.1 South Africa: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.4.9.3 South Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.4.9.3.1 South Africa: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.4.9.4 South Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.4.9.4.1 South Africa: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.4.9.4.2 South Africa: R&D Departments Market, by Type, 2018-2027 (USD Million)
  • 10.5 South and Central America: Pharmaceutical Continuous Manufacturing Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.5.3 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
      • 10.5.3.1 South and Central America: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
    • 10.5.4 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
      • 10.5.4.1 South and Central America: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
    • 10.5.5 South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
      • 10.5.5.1 South and Central America: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
      • 10.5.5.2 South and Central America: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.5.6 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
    • 10.5.7 Brazil: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.5.7.2.1 Brazil: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.5.7.3 Brazil: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.5.7.3.1 Brazil: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.5.7.4 Brazil: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.5.7.4.1 Brazil: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.5.7.4.2 Brazil: R&D Departments Market, by Type, 2018-2027 (USD Million)
    • 10.5.8 Argentina: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
        • 10.5.8.2.1 Argentina: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
      • 10.5.8.3 Argentina: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
        • 10.5.8.3.1 Argentina: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
      • 10.5.8.4 Argentina: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
        • 10.5.8.4.1 Argentina: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
        • 10.5.8.4.2 Argentina: R&D Departments Market, by Type, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of World: Impact Assessment of COVID-19 Pandemic

12. Pharmaceutical Continuous Manufacturing Market -Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 GEA Group
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Coperion GmbH
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Gericke AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Glatt GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Hosokawa Micron Group
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Munson Machinery Co., Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Powrex Corp
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 THERMO FISHER SCIENTIFIC INC.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 ACG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Cadmach Machinery Co. Pvt. Ltd.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Fette Compacting
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Freund-Vector Corporation
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 KORSCH AG
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 LEISTRITZ AG
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 ALEXANDERWERK AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hovione
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 6. North America Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 7. North America R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 9. US Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 10. US Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 11. US End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. US Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. US Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. US R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Canada: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 16. Canada: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 17. Canada: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Canada: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Canada: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Canada: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Canada: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Mexico: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 23. Mexico: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 24. Mexico: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Mexico: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Mexico: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Mexico: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Mexico: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Europe Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 30. Europe: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 31. Europe: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Europe: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Europe: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Europe: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Europe: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Germany: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 37. Germany: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 38. Germany: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Germany: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Germany: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Germany: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Germany: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 43. UK: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 44. UK: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 45. UK: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 46. UK: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 47. UK: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 48. UK: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 49. UK: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 50. France: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 51. France: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 52. France: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 53. France: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 54. France: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 55. France: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 56. France: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 57. Spain: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 58. Spain: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 59. Spain: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 60. Spain: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Spain: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 62. Spain: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Spain: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Italy: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 65. Italy: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 66. Italy: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Italy: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Italy: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Italy: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Italy: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 72. Asia Pacific: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 73. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 74. Asia Pacific: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 75. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Asia Pacific: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Asia Pacific: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 78. China: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 79. China: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 80. China: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 81. China: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 82. China: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 83. China: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 84. China: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 85. Japan: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 86. Japan: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 87. Japan: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 88. Japan: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 89. Japan: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Japan: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 91. Japan: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 92. India: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 93. India: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 94. India: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 95. India: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 96. India: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 97. India: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 98. India: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 99. South Korea: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 100. South Korea: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 101. South Korea: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 102. South Korea: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 103. South Korea: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 104. South Korea: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 105. South Korea: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 106. Australia: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 107. Australia: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 108. Australia: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 109. Australia: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 110. Australia: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 111. Australia: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 112. Australia: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 113. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 114. Middle East & Africa: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 115. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 116. Middle East & Africa: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 117. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 118. Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 119. Middle East & Africa: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 120. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 121. Saudi Arabia Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 122. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 123. Saudi Arabia End Product Manufacturing Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 124. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 125. Saudi Arabia Full-Scale Manufacturing Companies Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 126. Saudi Arabia R&D Departments Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 127. UAE: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 128. UAE: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 129. UAE: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 130. UAE: End Product Manufacturing Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 131. UAE: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 132. UAE: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 133. UAE: R&D Departments Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 134. South Africa: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 135. South Africa: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 136. South Africa: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 137. South Africa: End Product Manufacturing Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 138. South Africa: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 139. South Africa: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 140. South Africa: R&D Departments Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 141. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 142. South and Central America: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 143. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 144. South and Central America: End Product Manufacturing Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 145. South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 146. South and Central America: Full-Scale Manufacturing Companies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 147. South and Central America: R&D Departments Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 148. Brazil: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 149. Brazil: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 150. Brazil: Pharmaceutical Continuous Manufacturing Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 151. Brazil: End Product Manufacturing Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 152. Brazil: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 153. Brazil: Full-Scale Manufacturing Companies Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 154. Brazil: R&D Departments Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 155. Argentina: Pharmaceutical Continuous Manufacturing Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 156. Argentina: Semi-Continuous Systems Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 157. Argentina: Pharmaceutical Continuous Manufacturing Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 158. Argentina: End Product Manufacturing Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 159. Argentina: Pharmaceutical Continuous Manufacturing Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 160. Argentina: Full-Scale Manufacturing Companies Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 161. Argentina: R&D Departments Market, by Type- Revenue and Forecast to 2027 (USD Million)
  • Table 162. Recent Growth Strategies In The Pharmaceutical Continuous Manufacturing Market
  • Table 163. Glossary of Terms, Pharmaceutical Continuous Manufacturing Market

LIST OF FIGURES

  • Figure 1. Pharmaceutical Continuous Manufacturing Market Segmentation
  • Figure 2. Pharmaceutical Continuous Manufacturing Segmentation, By Region
  • Figure 3. Global Pharmaceutical Continuous Manufacturing Market Overview
  • Figure 4. The Integrated Systems Segment Held Largest Share Of Product Segment In Pharmaceutical Continuous Manufacturing Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Pharmaceutical Continuous Manufacturing Market, By Geography (US$ Million)
  • Figure 7. Global Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Million)
  • Figure 8. North America PEST Analysis
  • Figure 9. Europe: PEST Analysis
  • Figure 10. Asia Pacific PEST Analysis
  • Figure 11. Middle East & Africa PEST Analysis
  • Figure 12. South and Central America PEST Analysis
  • Figure 13. Global Pharmaceutical Continuous Manufacturing Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 14. Global Pharmaceutical Continuous Manufacturing Market - By Geography Forecast And Analysis - 2019- 2027
  • Figure 15. Market Positioning Of Key Players In Global Pharmaceutical Continuous Manufacturing Market
  • Figure 16. Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
  • Figure 17. Integrated Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. Continuous Granulators: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Continuous Blenders: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 ( US$ Million)
  • Figure 21. Continuous Compressors: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Continuous Coaters: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Continuous Dryers: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Controls: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Pharmaceutical Continuous Manufacturing Market Share, by application, 2019 and 2027 (%)
  • Figure 27. End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 28. Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 29. Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 30. API Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 31. Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
  • Figure 32. Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 33. Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 34. Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 35. R&D Departments: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 36. Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 37. Research Institutes: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 38. North America: Pharmaceutical Continuous Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 39. North America Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 40. North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)
  • Figure 41. US: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Canada: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Mexico: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Europe: Pharmaceutical Continuous Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 45. Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
  • Figure 47. Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 53. Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 54. China: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Japan: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 60. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country - 2019 & 2027, (%)
  • Figure 62. Saudi Arabia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. UAE: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. South Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 66. South and Central America Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
  • Figure 67. South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
  • Figure 68. Brazil: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 69. Argentina: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 70. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 71. Impact of COVID-19 Pandemic in Europe Country Markets
  • Figure 72. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 73. Impact of COVID-19 Pandemic in Rest of World Country Markets